ArticleScientific reports2026
Melanin concentrating hormone regulates bone cell activities and calcium metabolism in regenerating goldfish scales.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Previous studies in mice have reported that melanin-concentrating hormone (MCH) regulates bone calcification, an essential process in bone regeneration. However, the mechanisms by which MCH influences the activities of bone cells involved in calcification remain unclear. Goldfish scales, like mammalian bone, consist of osteoblasts, osteoclasts, and a calcified matrix, making regenerating goldfish scales a useful model for studying bone regeneration. In the present study, a single MCH treatment suppressed the expression of genes encoding proteins associated with osteoclast activity in cultured goldfish scales. Moreover, intraperitoneal administration of MCH decreased plasma calcium concentrations and tartrate-resistant acid phosphatase (TRAP) activity, an osteoclast activity marker, in goldfish 24 h after administration. Gene expression analysis suggested that MCH receptor 2 is involved in MCH-mediated regulation of calcification in goldfish scales. In contrast, continuous intraperitoneal administration of MCH elevated both alkaline phosphatase, an osteoblast marker, and TRAP activities in regenerating scales and resulted in decreased scale calcium levels. These results indicate that a single MCH treatment inhibits osteoclast activity in goldfish scales, leading to reduced plasma calcium levels, whereas prolonged MCH treatment affects both osteoclasts and osteoblasts in regenerating scales, thereby resulting in decreased calcium contents in the scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.